CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-04 | MORNEAU MICHAEL VP, Finance and Administration | Shares withheld for taxes | −7,616 | $4.22 | $32K | 94,035 |
| 2018-05-04 | Lian Brian President & CEO | Shares withheld for taxes | −10,086 | $4.22 | $43K | 1,483,012 |
| 2018-01-19 | MORNEAU MICHAEL Chief Financial Officer | Grant or award | +15,000 | 101,651 | ||
| 2018-01-19 | MORNEAU MICHAEL Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +52,500 | 52,500 | ||
| 2018-01-19 | Lian Brian President & CEO | Grant or award | +40,000 | 1,493,098 | ||
| 2018-01-19 | Lian Brian President & CEO | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2018-01-02 | Webster Stephen W Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2018-01-02 | SINGLETON J MATTHEW Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2018-01-02 | Rowland Charles A Jr Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2018-01-02 | MACARTNEY LAWSON Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2018-01-02 | FOEHR MATTHEW W Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2017-07-13 | LIGAND PHARMACEUTICALS INC 10% owner | Other disposition · Convertible Note (convertible into Common Stock) | −38,630 | $38,630.00 | $1.5B | 1,916,509 |
| 2017-07-01 | Rowland Charles A Jr Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2017-05-04 | MORNEAU MICHAEL Chief Financial Officer | Shares withheld for taxes | −8,192 | $1.34 | $11K | 80,604 |
| 2017-01-05 | MORNEAU MICHAEL Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +95,000 | 95,000 | ||
| 2017-01-05 | MORNEAU MICHAEL Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +17,605 | 17,605 | ||
| 2017-01-05 | Lian Brian President & CEO | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2017-01-05 | Lian Brian President & CEO | Grant or award · Stock Option (Right to Buy) | +34,931 | 34,931 | ||
| 2017-01-03 | FOEHR MATTHEW W Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2017-01-03 | SINGLETON J MATTHEW Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 |
Page 24 of 27 · 528 trades